BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21326957)

  • 1. The value of serum biomarkers (Bc1, Bc2, Bc3) in the diagnosis of early breast cancer.
    Atahan K; Küpeli H; Gür S; Yiğitbaşı T; Baskın Y; Yiğit S; Deniz M; Cökmez A; Tarcan E
    Int J Med Sci; 2011 Feb; 8(2):148-55. PubMed ID: 21326957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
    Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
    Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum biomarkers for detection of breast cancers: A prospective study.
    Mathelin C; Cromer A; Wendling C; Tomasetto C; Rio MC
    Breast Cancer Res Treat; 2006 Mar; 96(1):83-90. PubMed ID: 16322896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient biomarker panel for diagnosis of breast cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry.
    Yigitbasi T; Calibasi-Kocal G; Buyukuslu N; Atahan MK; Kupeli H; Yigit S; Tarcan E; Baskin Y
    Biomed Rep; 2018 Mar; 8(3):269-274. PubMed ID: 29456844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.
    Opstal-van Winden AW; Krop EJ; Kåredal MH; Gast MC; Lindh CH; Jeppsson MC; Jönsson BA; Grobbee DE; Peeters PH; Beijnen JH; van Gils CH; Vermeulen RC
    BMC Cancer; 2011 Aug; 11():381. PubMed ID: 21871081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies reactive with mucin expressed in breast cancer.
    Xing PX; Tjandra JJ; Stacker SA; Teh JG; Thompson CH; McLaughlin PJ; McKenzie IF
    Immunol Cell Biol; 1989 Jun; 67 ( Pt 3)():183-95. PubMed ID: 2477330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of serum proteomic mass spectrum analysis in breast cancer].
    Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
    Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
    Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
    Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum.
    Lebrecht A; Boehm D; Schmidt M; Koelbl H; Grus FH
    Cancer Genomics Proteomics; 2009; 6(2):75-83. PubMed ID: 19451091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer.
    Sun Y; Zhang J; Guo F; Zhao W; Zhan Y; Liu C; Fan Y; Wang J
    Med Sci Monit; 2016 Apr; 22():1152-60. PubMed ID: 27052600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.
    Becker S; Cazares LH; Watson P; Lynch H; Semmes OJ; Drake RR; Laronga C
    Ann Surg Oncol; 2004 Oct; 11(10):907-14. PubMed ID: 15383419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.
    Orlandi R; De Bortoli M; Ciniselli CM; Vaghi E; Caccia D; Garrisi V; Pizzamiglio S; Veneroni S; Bonini C; Agresti R; Daidone MG; Morelli D; Camaschella C; Verderio P; Bongarzone I
    Ann Oncol; 2014 Feb; 25(2):352-7. PubMed ID: 24306042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer.
    Tutzauer J; Sjöström M; Bendahl PO; Rydén L; Fernö M; Leeb-Lundberg LMF; Alkner S
    PLoS One; 2020; 15(4):e0231786. PubMed ID: 32302351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
    Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cotton leaf curl virus resistance in BC1, BC2, and BC3 progenies from an interspecific cross between Gossypium arboreum and Gossypium hirsutum.
    Nazeer W; Tipu AL; Ahmad S; Mahmood K; Mahmood A; Zhou B
    PLoS One; 2014; 9(11):e111861. PubMed ID: 25372141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.